2.690USD+4.66%Mkt Cap: 6.17M USDP/E: —Last update: 2026-05-26
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally…
Industry Peers
Medical Devices151.38BUSDP/E 24.3
119.84BUSDP/E 36.2
86.12BUSDP/E 24.2
54.95BSEKP/E 101.9
53.92BSEKP/E 22.9
52.13BDKKP/E 22.1
50.54BUSDP/E 47.4
39.31BEURP/E 18.6
Indicators:|
Key Statistics
Company
Market Cap6.17M USD
Enterprise Value1.07M USD
Revenue (TTM)3.91M USD
Gross Profit1.25M USD
Net Income (TTM)-10.57M USD
Revenue/Share3.827 USD
Last Price2.690 USD
Fiscal Year EndJun 2025
MR QuarterMar 2026
Employees53
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)7.51
PEG—
EV/EBITDA-0.10
EV/Revenue0.27
P/S1.61
P/B0.29
EPS (TTM)-11.62
EPS (Forward)0.35
52W Range
2.2702% of range24.90
52W High24.90 USD
52W Low2.270 USD
Profitability
Gross Margin40.85%
Oper. Margin-277.33%
EBITDA Margin-261.50%
Profit Margin-346.23%
ROE-352.75%
ROA-128.11%
Growth
Revenue Growth45.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.68M USD
CapEx (TTM)231.84K USD
FCF Margin-165.90%
FCF Yield-105.20%
Net Debt-5.01M USD
Net Debt/EBITDA0.49
Balance Sheet
Debt/Equity0.09
Current Ratio2.11
Quick Ratio1.80
Book Value/Sh8.957 USD
Cash/Share2.869 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateDec 16, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.2.39M
Float2.17M
Insiders3.57%
Institutions8.71%
Short Interest
Short Ratio0.5d
Short % Float2.52%
Short % Out.2.51%
Shares Short54.63K
Short (prev mo.)44.51K
Technical
SMA 502.997 (-10.3%)
SMA 2008.132 (-66.9%)
Beta4.24
S&P 52W Chg28.31%
Avg Vol (30d)158.41K
Avg Vol (10d)302.74K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—